MedTrace Logo

Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC-01)

NCT04731610 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 314

Last updated 2026-04-20

No results posted yet for this study

Summary

The primary objective of the study : to compare the Recurrence-Free survival (RFS) between arms. RFS is defined as time from randomisation to the first recurrence (either local-regional or distant) or death of any cause.

Conditions

  • Thymoma Malignant Recurrent

Interventions

OTHER

Radiotherapy

postoperative radiotherapy after complete resection of thymoma

OTHER

Surveillance after resection

Surveillance after tumour resection

Sponsors & Collaborators

  • Institut Curie

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-28
Primary Completion
2031-12-28
Completion
2032-12-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04731610 on ClinicalTrials.gov